No Data
No Data
Futu Morning Report | Non-farm data is arriving tonight! Goldman Sachs: This could determine whether there will be another rate cut in December; another major bank is optimistic! Wells Fargo raises its outlook for the S&P to 7007 points.
After hours, it surged over 8%! Lululemon's Q3 performance exceeded expectations; after accurately predicting that bitcoin would reach $100,000 this year, Standard Chartered's analyst is bullish again: predicting it will reach the significant milestone of $200,000 by the end of next year; OPEC+ has continued its three sets of production cut measures, extending the additional voluntary reduction of 2.2 million barrels per day for three months.
The CEO of unitedhealth's insurance business has been shot dead: bullets were found with special markings, roughly pointing to the topics "drag, refuse, argue".
The head of a major health insurance company in the usa was shot and there are new developments. The suspect left behind bullets with the words 'delay' and 'depose' on them, which may be related to the insurance company's refusal to pay claims. However, some experts point out that this could also be a deliberate clue left by the suspect to divert the attention of the police.
The pharmaceutical industry breathes a sigh of relief: pfizer and eli lilly and co CEOs reportedly had dinner with Trump.
① According to reports, Trump met with the CEOs of pfizer, eli lilly and co, and industry associations at Mar-a-Lago to discuss the agenda for the next four years; ② Robert F. Kennedy Jr.'s "Make America Healthy Again" agenda has raised strong concerns in the pharmaceutical industry, leading to a collective drop in stock prices after gaining the nomination for Secretary of Health.
Merck Shares Are Trading Higher After the Company Along With Ridgeback Biotherapeutics Initiated Phase 3 of the MOVe-NOW Trial to Evaluate Lagevrio.
Lilly's Zepbound Will First Be Given in the UK to Those With 'Highest Clinical Need'
How Much Did Americans Overspend On Weight Loss Medications in 2024? GoodRx Reveals